688266.SS
688266.SS
CNE100003RP1
SUZHOU ZELGEN BIOPHARMACEUTICAL
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 810.484.651 532.954.371
52.1%
Cost of Revenue 77.633.817 36.991.446
109.9%
Gross Profit 732.850.834 495.962.926
47.8%
928.229.685 683.282.250
35.8%
Operating Income -195.378.851 -187.319.324
4.3%
Pretax Income -168.654.783 -155.047.807
8.8%
Net Income Common Stockholders -162.946.168 -137.830.776
18.2%
-- --
--
-- --
--
ende